Price
No data yet.
Social Signal Score
Revenue
$418.76M+8.25%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Stuart Essig
- Sector
- Healthcare
- Industry
- Medical - Devices
- Employees
- 4,427
- Beta
- 1.21
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 1.32
Financials
Revenue
$418.76M+8.2%Net Income
$4.48M-89.6%EBITDA
$65.87M-25.3%Free Cash Flow
$37.65M-50.1%EPS (diluted)
$0.06-88.2%Shares Outstanding (diluted)
78.17M-8.5%Operating Expenses
$196.69MCash & Debt
$274.08MReturn of Capital
$0.00Revenue by Segment (annual)
$1.64BQuote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $1.64B | $-516.47M | $-6.73 |
| 2024 | $1.61B | $-6.94M | $-0.09 |
| 2023 | $1.54B | $67.74M | $0.87 |
| 2022 | $1.56B | $180.55M | $2.18 |
| 2021 | $1.54B | $169.07M | $2.00 |
| 2020 | $1.37B | $133.89M | $1.58 |
| 2019 | $1.52B | $50.20M | $0.59 |
| 2018 | $1.47B | $60.80M | $0.73 |
| 2017 | $1.19B | $64.74M | $0.83 |
| 2016 | $992.08M | $74.56M | $1.00 |
| 2015 | $882.73M | $-3.52M | $-0.05 |
| 2014 | $928.30M | $34.00M | $0.52 |
| 2013 | $836.21M | $-16.98M | $-0.30 |
| 2012 | $830.87M | $41.20M | $0.74 |
Valuation
IARThas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
130Social Signal Score
Mentions (1)
- Newszacks.com·5h ago·Positive
Is IART Still Attractive as Its Low Valuation Meets Execution Risks? Integra's steep valuation discount meets margin gains and cost savings, but modest growth, leverage and unresolved FDA risks keep execution in focus.
View source ↗
Earnings
Thu, Oct 29(in 2 months)
Consensus estimate $0.56 per share
Typical surprise +12.8% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 29$0.56 vs $0.48beat
- Tue, May 5$0.54 vs $0.41beat
- Thu, Feb 26$0.83 vs $0.79beat
- Thu, Oct 30$0.54 vs $0.43beat
- Thu, Jul 31$0.45 vs $0.43beat
- Mon, May 5$0.41 vs $0.43miss
Estimates and results for IART via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by IART officers and directors.
- Bought
- $102k
- Sold
- —
1 trade
0 trades
- Graves Jeffrey Abought
99 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.